Rani Therapeutics Holdings, Inc.
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
RANI$0.56-2.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity
CONDENSED Consolidated Statementsof Changes in STOCKHOLDERS’ (DEFICIT)/Equity
| Class A Common Stock · Class B Common Stock | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | AdditionalPaid InCapital | AccumulatedOtherComprehensiveGain | AccumulatedDeficit | Non-ControllingInterest | TotalStockholders'(Deficit)/Equity | |
| Balance at December 31, 2024 | 33,430 | $3 | 23,972 | $2 | $104,889 | $5 | $(102,907) | $1,501 | $3,493 |
| Issuance of common stock under employee equity plans, net of shares withheld for tax settlement | 140 | — | — | — | (23) | — | — | — | (23) |
| Non-controlling interest adjustment for changes in proportionate ownership in Rani LLC | — | — | — | — | 1 | — | — | (1) | — |
| Stock-based compensation | — | — | — | — | 2,241 | — | — | 1,684 | 3,925 |
| Net loss | — | — | — | — | — | — | (7,264) | (5,474) | (12,738) |
| Other comprehensive loss | — | — | — | — | — | (3) | — | (3) | (6) |
| Balance at March 31, 2025 | 33,570 | $3 | 23,972 | $2 | $107,108 | $2 | $(110,171) | $(2,293) | $(5,349) |
| Class A Common Stock · Class B Common Stock | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | AdditionalPaid InCapital | AccumulatedOtherComprehensiveLoss | AccumulatedDeficit | Non-ControllingInterest | TotalStockholders'Equity | |
| Balance at December 31, 2023 | 26,036 | $3 | 24,116 | $2 | $85,762 | $(12) | $(72,889) | $12,577 | $25,443 |
| Issuance of common stock under employee equity plans | 175 | — | — | — | — | — | — | — | — |
| Effect of exchanges of non-corresponding Class A Units of Rani LLC | 83 | — | — | — | — | — | — | — | — |
| Non-controlling interest adjustment for changes in proportionate ownership in Rani LLC | — | — | — | — | 45 | — | — | (45) | — |
| Stock-based compensation | — | — | — | — | 1,969 | — | — | 1,901 | 3,870 |
| Net loss | — | — | — | — | — | — | (7,483) | (7,296) | (14,779) |
| Other comprehensive gain | — | — | — | — | — | 1 | — | — | 1 |
| Balance at March 31, 2024 | 26,294 | $3 | 24,116 | $2 | $87,776 | $(11) | $(80,372) | $7,137 | $14,535 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.